ALS Canada
ALS Canada (ALS Society of Canada) is a Toronto-based nonprofit founded in 1977 that serves approximately 4,000 Canadians living with ALS through patient support, advocacy, and research funding as the only national voluntary health organization dedicated to the disease.
- Company typePrivate
- Founded1977
- HeadquartersToronto, Canada
- Headcount11–50
- GTM typeB2C
- OfferingServices
What ALS Canada does
ALS Canada, legally known as the ALS Society of Canada, is a Toronto-based charitable nonprofit founded in 1977 that operates as the only national voluntary health organization in Canada dedicated to amyotrophic lateral sclerosis (ALS). The organization serves approximately 4,000 Canadians currently living with ALS, along with their families and caregivers, providing support services, advocacy, and research funding for a progressive neuromuscular disease with no cure and a 1-in-300 lifetime risk. Its core offerings are programmatic rather than productized: it distributes free educational content (e.g., the book 'Letters to ALS: Our Journeys to Hope'), coordinates assistive-technology resources, convenes patients and clinicians, and leads policy advocacy including on Parliament Hill for sustained federal research investment through initiatives such as the Canadian Collaboration to Cure ALS.
Its underlying operating model is grant- and donation-funded nonprofit advocacy and community organizing. The organization does not sell a defined product or service portfolio; its revenue mechanics are not publicly disclosed and pricing information is not available. Distribution occurs through online channels, ALS clinics across Canada, and in-person professional forums (including the December 2025 Annual Meeting and Allied Professionals Forum in Toronto, which drew over 300 health professionals, caregivers, and patients). It maintains partnerships with the International Alliance of ALS/MND Associations, the U.S.-based ALS Association, the Canadian Collaboration to Cure ALS coalition, and corporate sponsors such as Tanabe Pharma Canada for content co-production. In 2025, Health Canada approved Qalsody (tofersen) for SOD1-ALS, a regulatory milestone the organization cites as evidence that ALS can be treatable when research is prioritized.
The organization has no disclosed technology platform, software products, AI/ML capabilities, or paid customer base. Its competitive position rests on its unique national mandate, four-decade operating history, established relationships with clinicians and policymakers, and its convening role across the Canadian ALS community. There is no headcount, no parent or subsidiary structure, and no disclosed financial data in the source material.
ALS Canada firmographics
Firmographics- Name
- ALS Canada
- Legal name
- ALS Society of Canada
- Website
- https://als.ca
- Company type
- Private
- Founded year
- 1977
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- ALS Canada (ALS Society of Canada) is a Toronto-based nonprofit founded in 1977 that serves approximately 4,000 Canadians living with ALS through patient support, advocacy, and research funding as the only national voluntary health organization dedicated to the disease.
- Ownership category
- akta.pro rank
ALS Canada industry classification
Industry- Product category
- Neuromuscular Disease Nonprofit Support Services
- NAICS
- Voluntary Health Organizations (813212), Social Advocacy Organizations (8133), Grantmaking and Giving Services (81321)
- SIC
- Services-Membership Organizations (8600), Services-Social Services (8300)
- akta.pro primary industry
- Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS) (BPAGACAA)
- akta.pro secondary industries
- Disability Services & Assistive Solutions (Accessibility, Assistive Tech) (BPAGALAM), Disability Rights & Accessibility Advocacy (BPAGAFAF)
Keywords
Where ALS Canada is headquartered
LocationHeadquarters
- HQ city
- Toronto
- HQ country
- Canada
- HQ region
- North America
Markets served
ALS Canada business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Others
Distribution channels2 records
Marketing channels3 records
ALS Canada product offering
Product offeringCore offering
ALS Canada (ALS Society of Canada) is a national charitable nonprofit organization that supports Canadians affected by amyotrophic lateral sclerosis (ALS) through patient and family support services, advocacy for policy and research funding, and funding of ALS research initiatives. It connects approximately 4,000 Canadians living with ALS with clinicians, researchers, and advocates through programs, professional forums, and free educational resources.
Product overview
Based on the source data, ALS Canada (referenced as ALS Society of Canada) is a charitable organization focused on ALS (amyotrophic lateral sclerosis) research advocacy, awareness, and community support. The available source material does not provide specific information about a product or service portfolio beyond general organizational activities including research funding, advocacy efforts, and community support programs. Note: A separate entity called "ALS Canada Ltd." is as a laboratory assay service provider, but this appears to be a distinct mineral analysis laboratory company rather than the same organization.
Differentiator
Problem solved
Functional benefit
Products and services
- Patient and Family Support Services Free support services for individuals living with ALS and their families, addressing emotional distress, community connection, and access to disease information and resources.
- ALS Research Advocacy and Policy Engagement Advocacy and policy engagement to drive sustained government and stakeholder investment in ALS research, awareness, and treatment access in Canada.
- ALS Research Funding Program Grant-making program that funds ALS research initiatives aimed at understanding, treating, and ultimately curing amyotrophic lateral sclerosis.
Companies that use ALS Canada
Customer profileSegments1 record
Ideal customer profiles2 records
ALS Canada technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
ALS Canada partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered minor and core.
- Tanabe Pharma CanadaminorTanabe Pharma Canada collaborated with ALS patient organizations across Canada to publish 'Letters to ALS: Our Journeys to Hope,' a book sponsored by Tanabe Pharma Canada as part of their long-standing commitment to the ALS community. The book is available free of charge online and in limited printed copies through ALS clinics and advocacy organizations.
- International Alliance of ALS/MND AssociationscoreThe International Alliance of ALS/MND Associations held its Annual Meeting and Allied Professionals Forum in early December 2025 in Toronto, co-hosted by ALS Society of Canada and the ALS Association. This partnership brings together over 300 health professionals, caregivers, and people living with ALS to explore assistive technologies and share knowledge.
- ALS AssociationcoreThe ALS Association partnered with ALS Society of Canada to co-host the Annual Meeting and Allied Professionals Forum in Toronto in December 2025. This cross-border collaboration represents a major international partnership between the two leading ALS organizations in North America.
- Canadian Collaboration to Cure ALScoreALS Canada led advocacy efforts on Parliament Hill in fall 2025 to support the Canadian Collaboration to Cure ALS initiative, reinforcing the need for sustained investment in ALS research. This represents a flagship advocacy partnership for advancing cure-focused research initiatives.
Scale indicators2 records
Recent moves4 records
Expansion highlights4 records
ALS Canada competitors and assessment
Company assessmentDirect peers
- ALS Association: The leading US-based ALS voluntary health organization and a current strategic partner of ALS Canada. Both organizations run parallel national programs in research funding, advocacy, and patient services, and are the most natural international peer for ALS Canada.
- Project ALS: US nonprofit funding ALS research and patient advocacy with a research-grant-led model. Closely comparable to ALS Canada in mission, research-funding focus, and reliance on high-net-worth and family-foundation donors.
- ALS Therapy Development Institute: US-based nonprofit biotech focused on pre-clinical ALS therapeutic development. Operates in the same disease space with a research-driven mandate comparable to ALS Canada's research-funding pillar.
- International Alliance of ALS/MND Associations: Global federation of ALS/MND patient organizations. ALS Canada co-hosted the Alliance's 2025 Annual Meeting in Toronto, demonstrating operational equivalence and a deeply comparable mission, member base, and event-driven model.
Broad incumbents
- MS Society of Canada: Larger Canadian voluntary health organization focused on multiple sclerosis. A comparable Canadian nonprofit in scale, structure, and research-funding/advocacy/service mix, but with a far larger addressable patient base. Useful as a structural benchmark.
- Parkinson Canada: Canadian nonprofit supporting people with Parkinson's disease. Operates a parallel model of research funding, advocacy, and patient services within the Canadian neurodegenerative-disease nonprofit space.
- Canadian Cancer Society: Canada's largest disease-focused voluntary health organization, providing research funding, advocacy, and patient support. Relevant as a structural and scale benchmark for ALS Canada's national nonprofit model.
Regional players
- Muscular Dystrophy Canada: Canadian nonprofit serving a related neuromuscular disease population. Comparable in structure, Canadian scope, research-funding role, and patient-services mix, but with a broader disease portfolio that competes for the same neuromuscular-disease donor dollar.
- ALS Quebec (Société SLA du Québec): Quebec-focused ALS nonprofit providing services and funding research. A direct provincial peer to ALS Canada, offering an alternative channel for Canadian ALS donors and a potential partnership/merger candidate.
- Les Turner ALS Foundation: Chicago-based ALS-specific nonprofit offering patient services, research grants, and advocacy. Smaller in geography but otherwise a structurally direct peer in disease focus, service mix, and donor-driven nonprofit model.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights6 records
Customer concentration
ALS Canada social profiles
Digital presenceALS Canada financial estimates
Financial estimateRevenue estimate
Valuation estimate
ALS Canada leadership team
Management profileNumber of profiles
ALS Canada funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ALS Canada M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ALS Canada
What does ALS Canada do?
ALS Canada (ALS Society of Canada) is a national charitable nonprofit organization that supports Canadians affected by amyotrophic lateral sclerosis (ALS) through patient and family support services, advocacy for policy and research funding, and funding of ALS research initiatives. It connects approximately 4,000 Canadians living with ALS with clinicians, researchers, and advocates through programs, professional forums, and free educational resources.
Is ALS Canada a public or private company?
ALS Canada is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was ALS Canada founded?
ALS Canada was founded in 1977. It employs 11 to 50 people.
Where is ALS Canada based?
ALS Canada is headquartered in Toronto, Canada, in the North America region.
Who are ALS Canada's main competitors?
Direct peers on record are ALS Association, Project ALS, ALS Therapy Development Institute and International Alliance of ALS/MND Associations. Broad incumbents are MS Society of Canada, Parkinson Canada and Canadian Cancer Society. Regional players are Muscular Dystrophy Canada, ALS Quebec (Société SLA du Québec) and Les Turner ALS Foundation.
Does ALS Canada have an API?
No public API is recorded for ALS Canada.
What industry is ALS Canada in?
ALS Canada's product category is Neuromuscular Disease Nonprofit Support Services. Its primary akta.pro industry code is BPAGACAA, Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS), with a secondary code of BPAGALAM, Disability Services & Assistive Solutions (Accessibility, Assistive Tech). Its NAICS code is 813212 and its SIC code is 8600.